Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Executive or director change
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 8-K Event Other events
  10. SC 13D/A Stake Beneficial Ownership Report
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 8-K Event Other events
  16. 8-K Event Other events
  17. 424B4 Offering Prospectus
  18. POS EX Other Post-effective Amendment
  19. EFFECT Other Notice of Effectiveness
  20. S-1MEF Other S-1MEF

Page 23 of 27 · 537 filings